Evaluating the Efficacy and Safety of 4% 5-Fluorouracil Cream in Patients with Actinic Keratosis: An Expert Opinion by Eggert Stockfleth, Markus V. Heppt, Nathalie Bégeault, Alain Delarue

Connect to this object online.

The Overall Number of Actinic Keratosis Lesions Is Not Predictable by the Number of Visible Lesions: Consequences for Field-Directed Therapies by Eggert Stockfleth, MD PhD, Nathalie Bégeault, MSc, Alain Delarue, MD

Connect to this object online.

Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial by Eggert Stockfleth, Thomas Jouary, Francesca Farnetani, Antonio Macaya Pascual, Cecilia De Almeida Agudo, Jean-Jacques Voisard, Nathalie Bégeault, Alain Delarue

Connect to this object online.

Impact of Xerosis in Patients With Cancer Receiving Epidermal Growth Factor Receptor or Mitogen-Activated Protein Kinase Inhibitors: ATIXI, A Non-Interventional, Prospective, Pilot... by Pietro Quaglino, Giuseppe Argenziano, Emi Dika, Michela Starace, Simone Amabile, Paolo Fava, Elvira Moscarella, Bianca Maria Piraccini, Alain Delarue, Olivia Dialla, Fabienne Zumaglini, Giampiero Girolomoni

Connect to this object online.